Analysis of Interleukin - 28 B Polymorphisms and Pegylated - 1 Interferon / Ribavirin Response of Indonesian Chronic Hepatitis C
نویسندگان
چکیده
10 Departments of 1 Microbiology and 9 Biochemistry, School of Medicine, Airlangga University, 11 Surabaya, East Java, Indonesia, 2 Indonesia-Japan Collaborative Research Center for Emerging 12 and Re-emerging Infectious Diseases, 3 Institute of Tropical Disease, Airlangga University, 13 Surabaya, East Java, Indonesia, 4 Division of Gastroenterohepatology, Department of Internal 14 Medicine, Dr Saiful Anwar General Hospital, Malang, East Java, Indonesia, 5 Division of 15 Gastroenterohepatology, Department of Internal Medicine, Sanglah General Hospital, Denpasar, 16 Bali, Indonesia, 6 Department of Microbiology, School of Medicine, Udayana University, 17 Denpasar, Bali, Indonesia, 7 Department of Internal Medicine, Dr. Soetomo General Hospital, 18 Surabaya, East Java, Indonesia, 8 Center for Infectious Diseases, Kobe University Graduate 19 School of Medicine, Kobe, Hyogo, Japan. 20 ∗Address correspondence to Maria I. Lusida, [email protected] 21 J and B.P.W contributed equally to this work. 22 23 JCM Accepts, published online ahead of print on 2 April 2014 J. Clin. Microbiol. doi:10.1128/JCM.00768-14 Copyright © 2014, American Society for Microbiology. All Rights Reserved.
منابع مشابه
Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1 Patients Treated by Pegylated Interferon and Ribavirin
Background: Nowadays, the immune response to hepatitis C (HCV) treatment has become a crucial issue mostly due to the interleukin 28B (IL-28B) polymorphism effects in chronic HCV patients. The aim of this study was to detect the polymorphism of IL-28B gene (rs12979860) in HCV genotype 1 patients treated with pegylated Interferon and Ribavirin. Methods...
متن کاملInfluence of Vitamin D Receptor Gene Polymorphisms on Response to Pegylated Interferon in Chronic Hepatitis B Egyptian Patients
Background: We explored the effect of vitamin D receptor gene (VDR) polymorphisms in response to PEG-IFN treatment in Egyptian chronic hepatitis B (CHB) patients. Methods: Two hundred hepatitis B virus (HBV) patients (42.3±10.7 years) on PEG-IFN α-2a (180 μg /kg for 48 weeks) and one hundred control subjects (37.3 ±12 years) were enrolled in the study. Vitamin D levels a...
متن کاملLIVER CANCER 25-27 CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin
Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy. Khan AJ, Saraswat VA, Choudhuri G, et al. Epidemiol Infect. 2014 Mar 18:1-10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24641916 SUMMARY We conducted a case-control study involving 150 genot...
متن کاملAssociation of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
The scavenger receptor type B class I(SR-BI) is a receptor for high-density lipoproteins(HDL) and one of entry factors for hepatitis C virus(HCV). We examined the association of single nucleotide polymorphisms(SNPs) of the SCARB1 gene, which encodes SR-BI, with virologic responses to pegylated interferon-based treatment in Asian chronic hepatitis C(CHC) patients. Human genomic and clinical data...
متن کاملFactors influencing therapeutic response to peginterferron plus ribavirin in the different genotypes of chronic hepatitis C
Abstract Background: Different factors like age, sex, route of infection, initial viral load, levels of liver function tests and genotypes may affect response to treatment in patients with chronic hepatitis C. The purpose of this study was to determine the role of these factors in the treatment of these patients. Methods: From 2004 to 2012, different genotypes of chronic HCV (Hepatitis C ...
متن کامل